104 related articles for article (PubMed ID: 9591136)
1. Doublex sequencing in molecular diagnosis of hereditary diseases.
Plaschke J; Voss H; Hahn M; Ansorge W; Schackert HK
Biotechniques; 1998 May; 24(5):838-41. PubMed ID: 9591136
[TBL] [Abstract][Full Text] [Related]
2. Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit.
Campos B; Díez O; Cortés J; Domènech M; Pericay C; Alonso C; Baiget M
Clin Chem Lab Med; 2001 May; 39(5):401-4. PubMed ID: 11434389
[TBL] [Abstract][Full Text] [Related]
3. Dideoxy fingerprinting assay for BRCA1 mutation analysis.
Lancaster JM; Berchuck A; Futreal PA; Wiseman RW
Mol Carcinog; 1997 Jul; 19(3):176-9. PubMed ID: 9254884
[TBL] [Abstract][Full Text] [Related]
4. Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresis.
Velasco E; Infante M; Durán M; Esteban-Cardeñosa E; Lastra E; García-Girón C; Miner C
Electrophoresis; 2005 Jun; 26(13):2539-52. PubMed ID: 15937982
[TBL] [Abstract][Full Text] [Related]
5. [Molecular biology techniques: research, transfer or routine?].
Vidaud M
Bull Cancer; 1996 Dec; 83(12):1043-5. PubMed ID: 9116373
[No Abstract] [Full Text] [Related]
6. Mutational analysis using enriched PCR and cycle sequencing.
Mitchell KR; Warshawsky D
Biotechniques; 1998 Jun; 24(6):1028-31. PubMed ID: 9631198
[No Abstract] [Full Text] [Related]
7. Rapid sequencing of the p53 gene with a new automated DNA sequencer.
Bharaj BS; Angelopoulou K; Diamandis EP
Clin Chem; 1998 Jul; 44(7):1397-403. PubMed ID: 9665415
[TBL] [Abstract][Full Text] [Related]
8. High-throughput resequencing in the diagnosis of BRCA1/2 mutations using oligonucleotide resequencing microarrays.
Schroeder C; Stutzmann F; Weber BH; Riess O; Bonin M
Breast Cancer Res Treat; 2010 Jul; 122(1):287-97. PubMed ID: 19941162
[TBL] [Abstract][Full Text] [Related]
9. Automated cycle sequencing with Taquenase: protocols for internal labeling, dye primer and "doublex" simultaneous sequencing.
Voss H; Nentwich U; Duthie S; Wiemann S; Benes V; Zimmermann J; Ansorge W
Biotechniques; 1997 Aug; 23(2):312-8. PubMed ID: 9266089
[TBL] [Abstract][Full Text] [Related]
10. Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method.
Casadei S; Cortesi L; Pensotti V; Radice P; Pierotti M; Amadori D; Calistri D
Br J Cancer; 2001 Sep; 85(6):845-9. PubMed ID: 11556835
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of enzymatic mutation detectiontrade mark in hereditary nonpolyposis colorectal cancer.
Otway R; Tetlow N; Hornby J; Kohonen-Corish M
Hum Mutat; 2000; 16(1):61-7. PubMed ID: 10874307
[TBL] [Abstract][Full Text] [Related]
12. The value of multi-modal gene screening in HNPCC in Quebec: three mutations in mismatch repair genes that would have not been correctly identified by genomic DNA sequencing alone.
McVety S; Li L; Thiffault I; Gordon PH; Macnamara E; Wong N; Australie K; Kasprzak L; Chong G; Foulkes WD
Fam Cancer; 2006; 5(1):21-8. PubMed ID: 16528605
[TBL] [Abstract][Full Text] [Related]
13. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques.
Nakagawa H; Hampel H; de la Chapelle A
Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938096
[TBL] [Abstract][Full Text] [Related]
16. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
[TBL] [Abstract][Full Text] [Related]
17. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes.
Wehner M; Mangold E; Sengteller M; Friedrichs N; Aretz S; Friedl W; Propping P; Pagenstecher C
Eur J Hum Genet; 2005 Aug; 13(8):983-6. PubMed ID: 15870828
[TBL] [Abstract][Full Text] [Related]
18. Optimized PCR labeling in mutational and microsatellite analysis.
Esposito DL; Palmirotta R; Verì MC; Mammarella S; D'Amico F; Curia MC; Aceto G; Crognale S; Creati B; Mariani-Costantini R; Battista P; Cama A
Clin Chem; 1998 Jul; 44(7):1381-7. PubMed ID: 9665413
[TBL] [Abstract][Full Text] [Related]
19. Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assay.
Abbaszadegan MR; Struewing JP; Brown KM; Snider JV; Goodsaid F; Gore-Langton R; Hughes MR
Genet Test; 1997-1998; 1(3):171-80. PubMed ID: 10464643
[TBL] [Abstract][Full Text] [Related]
20. A simple system for automated two-dimensional electrophoresis: applications to genetic testing.
Dhanda RK; Smith WM; Scott CB; Eng C; Vijg J
Genet Test; 1998; 2(1):67-70. PubMed ID: 10464599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
